Medicared For All Logo

Mark Hendrixson MD in Crossville, Tennessee

Home Tennessee Crossville

Mark Hendrixson MD has Medical Oncology as his primary medical specialty. Their primary office is: 29 E Stanley St in Crossville, Tennessee. There is an additional office location, for a total of two, for Mark Hendrixson MD that can be viewed further down. They attended University Of Tennessee, Hsc, College Of Medicine and graduated in 1990 (around 34 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Mark N Hendrixson MD Office Phone and Directions

Mark Hendrixson MD
29 E Stanley St
Crossville, Tennessee 38555
-


Patient Ratings
Please rate your experience with Mark Hendrixson MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...


Enter a starting address:


Healthcare Info for Mark Hendrixson MD

Additional Medical Specialties Include:
EMERGENCY MEDICINE, HEMATOLOGY, INTERNAL MEDICINE

Medical School: University Of Tennessee, Hsc, College Of Medicine
Graduation Year: 1990
The Primary Medical Specialty for Mark Hendrixson MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 34
PAC (PECOS ID)#: 0840197976
NPI #: 1457469223
NPI Created On: 08/29/2006
NPI Last Updated Listed as: 07/24/2023
Primary Taxonomy Code: 207RX0202X
License Number:
MD021724
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Blood test, basic group of blood chemicals
  3. Albumin (protein) level
  4. Amylase (enzyme) level
  5. Bilirubin level
  6. Glutamyltransferase (liver enzyme) level
  7. Phosphatase (enzyme) level
  8. Total protein level, blood
  9. Liver enzyme (sgot), level
  10. Liver enzyme (sgpt), level
  11. Complete blood cell count (red cells, white blood cell, platelets), automated test
  12. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  13. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  14. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  15. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  16. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
  17. Infusion of chemotherapy into a vein up to 1 hour
  18. Infusion of chemotherapy into a vein
  19. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  20. Irrigation of implanted venous access drug delivery device

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788262935

Being Disputed:: No

Product Related: No


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788262939

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788262941

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017023

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017025

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017027

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017029

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818609055

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ALIMTA

Open Associated Drug #1: 0002-7623-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: CYRAMZA

Associated Drug #2: 0002-7669-01

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: VERZENIO

Name Of Drug #3: 0002-6216-54

Drug or Biological: Drug

Product Category #4: Oncology

Name of Drug #4: RETEVMO

Associated Drug #4: 0002-2980-60


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818609057

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801992813

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: ZEJULA

Open Associated Drug #1: 69656-103-90


Additional Office Locations

1.
707 S Main St
Crossville, TN 38555
Group Members: 0

Phone: -

Enter a starting address:


Medical Oncology Professionals in Crossville

33 W Adams St
Crossville, TN
Tennessee Plateau Oncology Pllc

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry